Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 766,100 shares, a growth of 21.1% from the November 15th total of 632,500 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Ascentage Pharma Group International Stock Performance

OTCMKTS ASPHF opened at $6.45 on Monday. The stock has a fifty day simple moving average of $5.77 and a 200-day simple moving average of $3.78. Ascentage Pharma Group International has a twelve month low of $6.45 and a twelve month high of $6.45.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.